Vijaya Diagnostic Centre Q1 Results: Earnings call scheduled for Aug 7
Vijaya Diagnostic Centre Limited scheduled an earnings call for August 07, 2026, to review Q1FY27 results. Key executives, including MD Suprita Reddy and CFO Narasimha Raju, will participate. The session is moderated by JM Financial and accessible via multiple international dial-in numbers. This event supports regulatory transparency under SEBI norms.

*this image is generated using AI for illustrative purposes only.
Vijaya Diagnostic Centre Limited company name will host an earnings conference call on Friday, August 07, 2026, at 10:30 A.M. (IST) to discuss its financial results for the first quarter ended June 30, 2026. The announcement, made pursuant to Regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, provides investors with a direct channel to management regarding the company’s performance in Q1FY27. This disclosure ensures transparency ahead of the detailed financial reporting cycle.
The company notified both the National Stock Exchange of India Limited and BSE Limited of the upcoming session. Naga Vasudha Tadepalli, Company Secretary & Compliance Officer, signed the intimation letter dated July 28, 2026. The filing confirms that the discussion will focus exclusively on the financial outcomes of the period ending June 30, 2026, allowing stakeholders to assess operational trends early in the fiscal year.
Key Participants
Senior leadership from Vijaya Diagnostic Centre will address questions during the call. The participant list includes:
- Suprita Reddy, Managing Director & Chief Executive Officer
- Siva Rama Raju Vegesna, Chief Operating Officer
- Narasimha Raju, Chief Financial Officer
- Dhiren Gala, Head – Investor Relations & Corporate Development
This lineup indicates that strategic, operational, and financial aspects of the quarterly performance will be covered. Investors can expect insights into revenue drivers, margin dynamics, and future guidance from these executives.
Dial-In Details
JM Financial Institutional Securities Limited is moderating the conference call. Participants can join via universal dial-in numbers or toll-free international lines. Early connection is recommended to avoid technical delays.
| Region | Dial-In Number |
|---|---|
| Universal | +91 22 6280 1366 / +91 22 7115 8267 |
| USA | 1 866 746 2133 |
| UK | 0 808 101 1573 |
| Singapore | 800 101 2045 |
| Hong Kong | 800 964 448 |
For further assistance, investors may contact Amey Chalke, Abin Benny, or Gourav Bhama at JM Financial. The company also provided a Diamond Pass link for express joining.
Regulatory Context
The earnings call serves as a standard compliance mechanism under Indian securities regulations. By hosting this session, Vijaya Diagnostic Centre Limited fulfills its obligation to disseminate material information equally to all stakeholders. The safe harbour statement included in the invitation notes that forward-looking statements may be made, which are subject to risks and uncertainties that could cause actual results to differ materially.
Historical Stock Returns for Vijaya Diagnostic Centre
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.07% | +1.28% | +3.09% | +39.59% | +18.44% | +118.00% |
How might Vijaya Diagnostic Centre's Q1FY27 margin dynamics influence its competitive positioning against larger national diagnostic chains in the upcoming fiscal year?
What specific operational expansion strategies or new service verticals is management likely to prioritize based on the revenue drivers discussed in the call?
Will the CFO provide updated full-year guidance that accounts for potential regulatory changes in the Indian healthcare sector post-Q1?


































